About this trial

The specific study aims will be:

1. To design and develop the hardware and software of the VR+MT and MR+MT systems. 2. To test the feasibility of the VR+MT and MR+MT systems from the patients and to collect the feedback of users with respect to their experiences. 3. To examine the treatment effects of VR+MT and MR+MT compared to the traditional MT (i.e., control group) in patients with stroke by conducting a randomized controlled trial. 4. To identify who will be the possible good responders to VR+MT and MR+MT based on their baseline motor functions and mental imagery abilities.

Eligibility criteria

Qualifiers

diagnosed with unilateral stroke

age of 20 to 80 years

a baseline Fugl-Meyer Assessment of the Upper Extremity score of 20 to 60

able to follow the study instructions and provide the feedback of user experiences verbally

Disqualifiers

diagnosed with global or receptive aphasia

the presence of severe neglect

the existence of major medical problems or comorbidities that could interfere with upper-limb usage and pain, or disrupt visual or auditory perception

diagnosed with unilateral stroke

Trial design

Treatments tested in this trial

  • Virtual Reality-based Mirror Therapy (VR+MT)
  • Mixed Reality-based Mirror Therapy (MR+MT)
  • Traditional Mirror Therapy (MT)

Treatment groups

45 Participants
are divided into 3 treatment groups

Locations

1
Taoyuan Chang Gung Memorial Hospital333, Taoyuan City Taiwan

Sponsors and collaborators

Chang Gung Memorial Hospital

Lead sponsor